Clinical Trials · NCT05433584
A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes
- Phase
- Phase 4
- Recruitment status
- Active Not Recruiting
- Sponsor
- Eli Lilly and Company
- Enrollment
- 780
- Start date
- Aug 2022
- Locations
- 90 sites, 11 countries
- Primary endpoint
- Change from Baseline in Hemoglobin A1c (HbA1c)